ERNEST PHARMACEUTICALS LLC
Biotech · Private
Salmonella-based bacterial delivery system carrying active caspase-3 protein (EBT-002) for selective tumor cell apoptosis induction in hepatocellular carcinoma
ernestpharma.com →- Grants
- $2.0M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: A bacterial intracellular delivery platform for liver cancer | $225,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Bacterial delivery of phosphatase antagonists to metastatic breast cancer | $223,594 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Bacterial delivery of phosphatase antagonists to metastatic breast cancer | $223,594 | |
| Federal grant | Department of Health and Human Services · Phase I · Bacterial delivery of pro-apoptotic proteins in advanced hepatocellular carcinoma. | $284,249 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: A bacterial intracellular delivery platform for liver cancer | $1,000,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3105 | EPIVAX, INC. | — | — |
| 3106 | Cortendo | — | — |
| 3107 | MICROPURE GENOMICS INC | — | — |
| 3108 | ERNEST PHARMACEUTICALS LLC | — | — |
| 3109 | MECHASIM INC. | — | — |
| 3110 | ESCAZYME BIOCHEMICALS, LLC | — | — |
| 3111 | SUR180 THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Intracellular Delivery Of Therapeutic Proteins Designed To Invade And Autonomously Lyse And Methods Of Use Thereofapplication
- Intracellular Delivery Of Therapeutic Proteins Designed To Invade And Autonomously Lyse And Methods Of Use Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.